GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Other Operating Expense

HLB Therapeutics Co (XKRX:115450) Other Operating Expense : ₩8,543 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Other Operating Expense?

HLB Therapeutics Co's Other Operating Expense for the three months ended in Mar. 2025 was ₩2,290 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩8,543 Mil.

HLB Therapeutics Co's quarterly Other Operating Expense declined from Sep. 2024 (₩2,513 Mil) to Dec. 2024 (₩1,869 Mil) but then increased from Dec. 2024 (₩1,869 Mil) to Mar. 2025 (₩2,290 Mil).

HLB Therapeutics Co's annual Other Operating Expense increased from Dec. 2022 (₩5,527 Mil) to Dec. 2023 (₩5,874 Mil) and increased from Dec. 2023 (₩5,874 Mil) to Dec. 2024 (₩8,337 Mil).


HLB Therapeutics Co Other Operating Expense Historical Data

The historical data trend for HLB Therapeutics Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Other Operating Expense Chart

HLB Therapeutics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,804.15 6,962.20 5,527.03 5,874.19 8,337.47

HLB Therapeutics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,084.03 1,871.70 2,513.12 1,868.62 2,289.51

HLB Therapeutics Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,543 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Therapeutics Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co Headlines

No Headlines